Ambalal Sarabhai Enterprises Ltd. | Small-cap | Healthcare
₹32.62
-2.04%
| Ambalal Sarabhai Stock Comparison:
Ambalal Sarabhai vs Sun PharmaceuticalAmbalal Sarabhai vs Divi's LaboratoriesAmbalal Sarabhai vs Sun Pharma AdvancedAmbalal Sarabhai vs Aarti DrugsAmbalal Sarabhai vs Sequent ScientificAmbalal Sarabhai vs NIFTY 50 | Market
TL;DR Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Jun 2025

Income Metrics

Revenue 403.4M
Gross Profit 170.6M 42.30%
Operating Income 6.0M 1.49%
Net Income 82.2M 20.39%
EPS (Diluted) ₹1.07

Balance Sheet Metrics

Total Assets 2.7B
Total Liabilities 1.3B
Shareholders Equity 1.4B
Debt to Equity 0.93

Cash Flow Metrics

Revenue & Profitability Trend

Ambalal Sarabhai Income Statement From 2021 to 2025

Metric20252024202320222021
Revenue i2.0B1.7B1.7B1.9B1.6B
Cost of Goods Sold i1.2B1.1B1.1B1.2B1.0B
Gross Profit i723.7M641.9M622.1M757.9M589.4M
Gross Margin % i37.1%37.1%36.7%38.9%36.3%
Operating Expenses
Research & Development i165.0K2.2M1.1M756.0K1.5M
Selling, General & Administrative i127.3M126.3M113.3M124.6M146.5M
Other Operating Expenses i162.8M150.8M157.1M127.6M70.2M
Total Operating Expenses i290.3M279.3M271.5M253.0M218.1M
Operating Income i92.4M52.4M70.6M237.7M59.3M
Operating Margin % i4.7%3.0%4.2%12.2%3.6%
Non-Operating Items
Interest Income i20.1M18.6M27.6M14.0M11.1M
Interest Expense i42.4M57.0M23.9M16.7M27.1M
Other Non-Operating Income-----
Pre-tax Income i48.3M66.5M151.7M541.9M325.4M
Income Tax i-981.0K9.7M37.2M69.8M31.9M
Effective Tax Rate % i-2.0%14.6%24.5%12.9%9.8%
Net Income i49.3M56.8M114.5M472.2M293.5M
Net Margin % i2.5%3.3%6.7%24.2%18.1%
Key Metrics
EBITDA i205.0M159.2M208.7M444.7M227.8M
EPS (Basic) i₹0.64₹0.74₹1.49₹6.16₹3.83
EPS (Diluted) i₹0.64₹0.74₹1.49₹6.16₹3.83
Basic Shares Outstanding i7663329676633296766332967663329676633296
Diluted Shares Outstanding i7663329676633296766332967663329676633296

Income Statement Trend

Ambalal Sarabhai Balance Sheet From 2021 to 2025

Metric20252024202320222021
Assets
Current Assets
Cash & Equivalents i48.9M107.5M101.3M121.0M147.4M
Short-term Investments i38.3M159.4M150.8M133.6M131.2M
Accounts Receivable i441.4M262.6M273.4M280.6M388.1M
Inventory i236.3M161.8M174.3M151.4M159.7M
Other Current Assets48.2M64.3M30.4M32.3M29.7M
Total Current Assets i1.2B1.2B1.1B1.2B1.2B
Non-Current Assets
Property, Plant & Equipment i50.6M34.4M37.8M25.0M11.1M
Goodwill i490.2M490.3M490.6M490.7M490.7M
Intangible Assets i80.0K185.0K220.0K346.0K370.0K
Long-term Investments-----
Other Non-Current Assets981.0K663.0K2.5M15.8M121.0K
Total Non-Current Assets i1.5B1.3B1.3B1.1B894.6M
Total Assets i2.7B2.5B2.5B2.3B2.1B
Liabilities
Current Liabilities
Accounts Payable i501.5M367.0M368.4M473.0M504.0M
Short-term Debt i418.7M363.4M339.3M233.9M225.6M
Current Portion of Long-term Debt-----
Other Current Liabilities1.7M2.0M5.0M1.7M85.4M
Total Current Liabilities i1.2B1.0B1.0B1.1B1.3B
Non-Current Liabilities
Long-term Debt i90.1M97.7M112.6M33.6M53.7M
Deferred Tax Liabilities i03.2M339.0K0-
Other Non-Current Liabilities-----
Total Non-Current Liabilities i96.6M107.7M119.4M51.8M76.2M
Total Liabilities i1.3B1.1B1.1B1.1B1.4B
Equity
Common Stock i766.3M766.3M766.3M766.3M766.3M
Retained Earnings i-28.3M-56.8M-120.2M-231.4M-699.2M
Treasury Stock i-----
Other Equity-----
Total Shareholders Equity i1.4B1.4B1.3B1.2B738.9M
Key Metrics
Total Debt i508.9M461.1M452.0M267.5M279.4M
Working Capital i-19.2M162.3M80.7M147.2M-79.5M

Balance Sheet Composition

Ambalal Sarabhai Cash Flow Statement From 2021 to 2025

Metric20252024202320222021
Operating Activities
Net Income i48.3M66.5M151.7M541.9M325.4M
Depreciation & Amortization i-----
Stock-Based Compensation i-----
Working Capital Changes i-354.9M-71.6M11.4M-168.2M-227.0M
Operating Cash Flow i-299.7M-29.3M109.4M505.0M114.4M
Investing Activities
Capital Expenditures i-25.5M-24.5M-192.3M35.8M89.8M
Acquisitions i----0
Investment Purchases i-----
Investment Sales i---292.0K200.0K
Investing Cash Flow i129.6M-24.5M-192.3M36.1M88.9M
Financing Activities
Share Repurchases i-----
Dividends Paid i-----
Debt Issuance i-----
Debt Repayment i-----
Financing Cash Flow i49.3M29.7M-8.0M-146.8M-29.1M
Free Cash Flow i-203.3M16.1M-149.4M-42.4M-47.6M
Net Change in Cash i-120.8M-24.1M-91.0M394.3M174.2M

Cash Flow Trend

Ambalal Sarabhai Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 20.68
Price to Book 1.88
Price to Sales 1.34
PEG Ratio 0.01

Profitability Ratios

Profit Margin 6.50%
Operating Margin 1.49%
Return on Equity 3.52%
Return on Assets 1.83%

Financial Health

Current Ratio 0.98
Debt to Equity 36.35
Beta -0.12

Per Share Data

EPS (TTM) ₹1.66
Book Value per Share ₹18.27
Revenue per Share ₹25.10

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
ambalalsa2.6B20.681.883.52%6.50%36.35
Sun Pharmaceutical 4.0T38.235.5015.08%19.29%3.26
Divi's Laboratories 1.6T70.9210.9114.64%23.89%0.03
Sun Pharma Advanced 47.4B-13.85-21.83157.88%-53.22%-1.24
Aarti Drugs 44.1B23.413.2212.28%7.80%44.92
Sequent Scientific 43.7B153.366.202.84%1.85%62.47

Financial data is updated regularly. All figures are in the company's reporting currency.